Evidence map›Paper›PMID 36715223›Full record

ArticleeLife2023

Mary F Fontana, Erica Ollmann Saphire, Marion Pepper

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Differences in phenotype between long-lived memory B cells againstbioRxiv : the preprint server for biology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mary F FontanaDepartment of Immunology, University of Washington School of Medicine, Seattle, United States.ORCID 0000-0003-3630-181X
Erica Ollmann SaphireCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, United States.
Marion PepperDepartment of Immunology, University of Washington School of Medicine, Seattle, United States.ORCID 0000-0001-7278-0147
University of Washington · USLa Jolla Institute for Immunology · US

Funding

Inducing durable, protective immune memory against malariaU01AI142001 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI KAPPE, STEFAN HI, PEPPER, MARION · 2019 to 2023
$5.5M
The Development and Function of Plasmodium-specific memory B cellsR01AI118803 · NIAID · UNIVERSITY OF WASHINGTON · PI PEPPER, MARION · 2017 to 2021
$3.0M
Generating a novel dual stage malaria vaccineR21AI166022 · NIAID · UNIVERSITY OF WASHINGTON · PI PEPPER, MARION · 2021 to 2022
$485k
Acquisition of BD FACSymphony A3 Lite Flow CytometerS10OD024979 · OD · UNIVERSITY OF WASHINGTON · PI BLACK, MICHELE C · 2020 to 2020
$344k
NIAID NIH HHS R01 AI118803NIAID NIH HHS R21 AI166022NIAID NIH HHS U01 AI142001NIH HHS 122353SUB / 5UO1AI42001-02NIH HHS 1ROAI118803-01ANIH HHS S10 OD024979Wellcome Trust 1016766
6 · The paper itself

Abstract

Naturally acquired immunity to malaria develops only after many years and repeated exposures, raising the question of whether

Indexed as

MalariaPlasmodiumPlasmodium chabaudiAnimalsDendritic CellsImmunizationMiceMice, Inbred C57BLT Follicular Helper CellsT-Lymphocytes, Helper-Inducerantibodygerminal centerimmunologyinfectious diseaseinflammationmalariamicrobiologymousePlasmodium chabaudiT cellsT follicular helper cells

Identifiers

PMID36715223
PMCPMC9886276
OpenAlexW4318478334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.